Thanks mate - that was very helpful to watch. I always feel a lot more secure with my investment when someone like Zane is at the helm.
To be clear my understanding is that the first pathway is the supply of the raw product and the second pathway is FijiKava branded products. You'd imagine the second pathway will provide for higher margins and that's where the company will try and focus on growing - and that's the deal with Coles (and this one springboard into other deals as others have discussed).
I read the deal with Blackmores as more of the supply of raw product and the deal with PuMate as a split of the two pathways (though I suspect leaning more towards the supply of the raw product). Either way, I agree it all sounds really encouraging.
- Forums
- ASX - By Stock
- CCO
- MAJOR Q3/Q4 Catalysts - $14M MC (Blackmores/Coles Onboard)
MAJOR Q3/Q4 Catalysts - $14M MC (Blackmores/Coles Onboard), page-168
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CCO (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.63M |
Open | High | Low | Value | Volume |
0.8¢ | 0.9¢ | 0.8¢ | $8.571K | 1.033M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 16786389 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 3809204 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
22 | 16786389 | 0.008 |
28 | 6442992 | 0.007 |
6 | 3058166 | 0.006 |
2 | 1100000 | 0.005 |
3 | 9136969 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 3809204 | 6 |
0.010 | 6687222 | 12 |
0.011 | 10991876 | 13 |
0.012 | 9313237 | 9 |
0.013 | 8588820 | 7 |
Last trade - 15.59pm 12/11/2024 (20 minute delay) ? |
Featured News
CCO (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online